Combination chemotherapy versus single-agent chemotherapy during preoperative chemoradiation for resectable rectal cancer-Reference-Cited by-同舟云学术

Combination chemotherapy versus single-agent chemotherapy during preoperative chemoradiation for resectable rectal cancer

Published:2015-10-21 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Resende Heloisa M¹,Jacob Luiz Felipe Pitzer²,Quinellato Luciano Vasconcellos²,Matos Delcio³,da Silva Edina MK⁴

Affiliation:

1. Escola Paulista de Medicina, Universidade Federal de São Paulo; Post-Graduation Program Emergency Medicine and Evidence Based Medicine of the Federal University of São Paulo (UNIFESP); Rua Borges Lagoa 564 cj 64 Vl. Clementino São Paulo Brazil 04038-000

2. Centro Universitário de Volta Redonda; Medicine School; Volta Redonda Brazil

3. Escola Paulista de Medicina, Universidade Federal de São Paulo; Department of Gastroenterological Surgery; Rua Edison 278, Apto 61 Campo Belo São Paulo São Paulo Brazil 04618-031

4. Universidade Federal de São Paulo; Emergency Medicine and Evidence Based Medicine; Rua Borges Lagoa 564 cj 64 Vl. Clementino São Paulo São Paulo Brazil 04038-000

Publisher

Wiley

Subject

Pharmacology (medical)

Reference36 articles.

1. Primary tumor response to preoperative chemoradiation with or without oxaliplatin in locally advanced rectal cancer: pathologic results of the STAR-01 randomized phase III trial;Aschele;Journal of Clinical Oncology,2011

2. Comparison of two neoadjuvant chemoradiotherapy regimens for locally advanced rectal cancer: results of the phase III trial ACCORD 12/0405-PRODIGE 2;Gérard;Journal of Clinical Oncology,2010

3. Clinical outcome of the ACCORD 12/0405 PRODIGE 2 randomized trial in rectal cancer;Gérard;Journal of Clinical Oncology,2012

4. Capecitabine and oxaliplatin in the preoperative multimodality treatment of rectal cancer: surgical end points from National Surgical Adjuvant Breast and Bowel Project trial R-04;O'Connell;Journal of Clinical Oncology,2014

5. The impact of capecitabine and oxaliplatin in the preoperative multimodality treatment in patients with carcinoma of the rectum;Roh;Journal of Clinical Oncology,2011

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Radiotherapy for Rectal Cancer: How Much is Enough?;Clinics in Colon and Rectal Surgery;2023-08-21

2. A Local Strategy Toward Concurrent Chemoradiotherapy Based on Fibrin Gel for Postsurgical Cancer Treatment;International Journal of Radiation Oncology*Biology*Physics;2023-08

3. Is There a Benefit of Oxaliplatin in Combination with Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer? An Updated Meta-Analysis;Cancers;2021-11-30

4. Immunological consequences of chemotherapy: Single drugs, combination therapies and nanoparticle-based treatments;Journal of Controlled Release;2019-07

5. Addition of Platinum Derivatives to Fluoropyrimidine-Based Neoadjuvant Chemoradiotherapy for Stage II/III Rectal Cancer: Systematic Review and Meta-Analysis;JNCI: Journal of the National Cancer Institute;2019-05-11